Clinical Trial · NCT07510906

Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer

Overview

The goal of this study is to evaluate the imaging capabilities of a new prostate-targeted PET system (P-PET) and determine whether it could be useful in detecting prostate cancer by comparing SOC whole body PET imaging. This pilot study will include adult men who have been diagnosed with or are suspected to have prostate cancer. Participants will undergo a standard-of-care PET/CT scan followed by an additional P-PET scan designed to provide detailed images of the prostate. The images from the two scans to assess how well the P-PET system can detect prostate cancer.

Sponsor

Sunnybrook Health Sciences Centre

Phase

N/A

Contacts

Maureen Dougan (CONTACT)

maureen.dougan@sjhc.london.on.ca

519-685-8300

Stephen Pautler, BSc MD FRCSC (PRINCIPAL_INVESTIGATOR)

ClinicalTrials.gov

NCT07510906

Drug / Compound

PSMA-1007

Isotope(s):

Target(s):

PSMA

Ligand Class: Small Molecules

Eligibility

Inclusion

Qualitative comparison of PET scans acquired by the P-PET vs. WB PET

Exclusion

Unable to comply with the length of scan time due to the study imaging.